ROR2 expression was also shown to activate AKT signaling in multiple myeloma [49], whereas PTK7 expression elicits anti-apoptotic effects in T cell acute lymphoblastic leukemia (T-ALL) [50]. This evidence concerns the gene AKT1 and T-cell acute lymphoblastic leukemia.